XML 26 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCK-BASED COMPENSATION
9 Months Ended
Sep. 30, 2017
STOCK-BASED COMPENSATION

NOTE 2. STOCK-BASED COMPENSATION

Presented below is a summary of the stock-based compensation cost and associated tax benefit included in the accompanying consolidated statements of operations:

Three Months EndedNine months ended
September 30,September 30,
2017201620172016
Stock-based compensation cost$31.8$23.9$88.9$72.8
Tax benefit$10.3$7.8$28.8$23.7

During the first nine months of 2017, the Company granted 0.2 million employee stock options, which had a weighted average grant date fair value of $30.00 per share based on the Black-Scholes option-pricing model. The Company also granted 1.0 million shares of restricted stock in the first nine months of 2017, which had a weighted average grant date fair value of $113.39 per share. Both the employee stock options and restricted stock generally vest ratably over a four-year period. Additionally, the Company granted approximately 0.2 million shares of performance-based awards whereby the number of shares that ultimately vest are based on the achievement of certain non-market based performance metrics of the Company over a three-year period. The weighted average grant date fair value of these awards was $109.36 per share.

The following weighted average assumptions were used in determining the fair value for options granted in 2017:

Expected dividend yield1.34%
Expected stock volatility26.8%
Risk-free interest rate2.19%
Expected holding period6.5 years
Grant date fair value$30.00

Unrecognized compensation expense at September 30, 2017 was $8.0 million and $150.1 million for stock options and unvested restricted stock, respectively, which is expected to be recognized over a weighted average period of 1.4 years and 1.6 years, respectively. Additionally, there was $27.7 million of unrecognized compensation expense relating to the aforementioned non-market based performance-based awards, which is expected to be recognized over a weighted average period of 1.1 years.

The following tables summarize information relating to stock option exercises and restricted stock vesting:

Nine months ended
September 30,
Exercise of stock options:20172016
Proceeds from stock option exercises$44.0$67.7
Aggregate intrinsic value$75.7$67.8
Tax benefit realized upon exercise$26.9$23.1
Number of shares exercised1.01.4
Nine months ended
September 30,
Vesting of restricted stock:20172016
Fair value of shares vested$109.1$92.8
Tax benefit realized upon vesting$34.6$29.5
Number of shares vested1.01.0
Nine months ended
September 30,
Vesting of performance-based restricted stock:20172016
Fair value of shares vested$19.5$23.6
Tax benefit realized upon vesting$6.9$8.4
Number of shares vested0.20.2